Jaehong Kim, Ph.D.

Dr. Jaehong Kim is a health economist with extensive expertise in Health Economics and Outcomes Research (HEOR), market access, and health policy. As a consultant at FTI Consulting, he works with private healthcare sector clients to evaluate the economic and clinical impact of medical technologies. His dedication to advancing healthcare efficiency and value makes him a trusted partner for organizations navigating a competitive and evolving market while supporting sustainable healthcare systems.

Dr. Kim has a distinguished track record in conducting Health Technology Assessments (HTA) to provide clients with evidence-based solutions that inform pricing, reimbursement, and market access strategies. As part of this work, he applies cutting-edge value assessment models to incorporate broader value elements, such as the uncertainty of patients’ health outcomes and the dynamic nature of healthcare markets (e.g., real option value, spillover effects), offering tailored, value-based pricing strategies to help clients navigate complex regulatory landscapes. Moreover, by incorporating real-world evidence and payer-specific needs, Dr. Kim provides actionable insights into the budgetary implications of new medical technologies, supporting their sustainable adoption and enabling short- and long-term financial planning.
Additionally, Dr. Kim applies advanced economic analysis methods to assess the societal and economic impact of policy interventions aimed at improving medical care access. His recent projects include evaluating policies to advance the regional adoption of innovative medical treatments and promote health equity. Through these analyses, Dr. Kim helps clients align their strategies with public health goals by addressing healthcare needs, regulatory priorities, and health disparities, while enhancing credibility, meeting stakeholder expectations, and positioning themselves to maximize both societal value and business growth.
As a researcher, Dr. Kim contributed to the development of the Generalized Cost-Effectiveness Analysis (GCEA) framework, a tool that helps stakeholders comprehensively capture the societal benefits and costs of medical technologies, in collaboration with leading health economists. The white paper Dr. Kim co-authored provides a user guide for implementing GCEA for health economics researchers and practitioners. Moreover, Dr. Kim has studied the interplay between medical innovation and healthcare markets from an industrial organization perspective. His work includes examining how the competitive dynamics of the pharmaceutical market influence firms’ R&D decisions, as well as how breakthrough healthcare technologies impact health insurance demand. His collaborations with colleagues and clients have resulted in peer-reviewed publications in prominent medical and health economics journals, including Diabetes Care, Annals of the American Thoracic Society, American Journal of Managed Care, and Value in Health, among others.
Dr. Kim holds a Doctoral degree in Health Economics from the University of Southern California, as well as Master’s and Bachelor’s degrees in Economics from Korea University, Seoul, Republic of Korea.

.